The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 09, 2025

Filed:

Apr. 11, 2023
Applicant:

Takeda Pharmaceutical Company Limited, Osaka, JP;

Inventors:

Meinhard Hasslacher, Vienna, AT;

Christian Fiedler, Vienna, AT;

Artur Mitterer, Orth/Donau, AT;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 9/64 (2006.01); C12M 1/00 (2006.01); C12N 11/14 (2006.01);
U.S. Cl.
CPC ...
C12N 9/6489 (2013.01); C12M 47/12 (2013.01); C12N 11/14 (2013.01); C12Y 304/24087 (2013.01);
Abstract

Provided herein are methods for purifying recombinant A Disintegrin-like and Metallopeptidase with Thrombospondin Type 1 Motif 13 (ADAMTS13) protein from a sample. The method comprises enriching for ADAMTS13 protein by chromatographically contacting the sample with hydroxyapatite under conditions that allow ADAMTS13 protein to appear in the eluate or supernatant from the hydroxylapatite. The methods may further comprise tandem chromatography with a mixed mode cation exchange/hydrophobic interaction resin that binds ADAMTS13 protein. Additional optional steps involve ultrafiltration/diafiltration, anion exchange chromatography, cation exchange chromatography, and viral inactivation. Also provided herein are methods for inactivating virus contaminants in protein samples, where the protein is immobilized on a support. Also provided herein are compositions of ADAMTS13 prepared according to said methods.


Find Patent Forward Citations

Loading…